Literature DB >> 12822875

Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa.

Ayse L Mindikoglu1, Abhinandana Anantharaju, Magdalene George, Nikunj N Shah, Jaime Villanueva, David H van Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12822875     DOI： 10.1023/a:1023777031589

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  24 in total

1.  Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).

Authors:  C Kositchaiwat; A Chuansumrit
Journal:  Thromb Haemost       Date:  2001-10       Impact factor: 5.249

2.  Coagulopathy of Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 3.  Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.

Authors:  U Hedner
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

4.  Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.

Authors:  M Berrettini; G Mariani; M Schiavoni; A Rocino; T Di Paolantonio; G Longo; M Morfini
Journal:  Haematologica       Date:  2001-06       Impact factor: 9.941

Review 5.  Recombinant factor VIIa (Novoseven) as a hemostatic agent.

Authors:  U Hedner
Journal:  Semin Hematol       Date:  2001-10       Impact factor: 3.851

Review 6.  Splenomegaly, hypersplenism and coagulation abnormalities in liver disease.

Authors:  P A McCormick; K M Murphy
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  2000-12

7.  Clinical aspects of bleeding complications in cirrhotic patients.

Authors:  A Craxì; C Cammà; M Giunta
Journal:  Blood Coagul Fibrinolysis       Date:  2000-04       Impact factor: 1.276

8.  Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study.

Authors:  A Tran; J P Villeneuve; M Bilodeau; B Willems; D Marleau; D Fenyves; R Parent; G Pomier-Layrargues
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

9.  Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.

Authors:  B White; H O'Connor; O P Smith
Journal:  Blood Coagul Fibrinolysis       Date:  2000-03       Impact factor: 1.276

10.  Hepatitis C virus transmission through quarantine fresh-frozen plasma.

Authors:  A Humpe; T J Legler; C M Nübling; J Riggert; G Unger; C Wolf; K H Heermann; M Köhler
Journal:  Thromb Haemost       Date:  2000-11       Impact factor: 5.249
View more
  1 in total

Review 1.  The emerging role of recombinant-activated factor VII in neurocritical care.

Authors:  Matthew E Fewel; Paul Park
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.